Amgen 8-K
NegativeDeal terminated
Kyowa Kirin license and collaboration agreement set to end upon regulatory approval.
Filed 2026-01-30 08:00 ET
- 1.02 Termination of a Material Agreement
- 9.01 Financial Statements and Exhibits
Summary
Termination of Amgen’s license and collaboration agreement with Kyowa Kirin. The companies agreed to end their 6/1/2021 agreement; termination takes effect upon regulatory approval.
Key Figures
- Termination agreement date: 1/30/2026; counterparty: Kyowa Kirin.
Investor Takeaways
- Regulatory approval is the next trigger for the termination to become effective.
The summary is written by an AI model reading the filing.
Model 005 · prompt 01d34d48e3